Trials / Recruiting
RecruitingNCT07106723
Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL
A Clinical Study of the Safety and Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Combination With CD7-CART in the Treatment of CD7+ T-Cell Lymphoma
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of autologous hematopoietic stem cell transfer (ASCT) combined with CD7-CART in the treatment of CD7+ TCL
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASCT+CD7-CART | Intravenous infusion of CD7-CART 3 days after ASCT |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2029-01-07
- Completion
- 2030-01-07
- First posted
- 2025-08-06
- Last updated
- 2025-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07106723. Inclusion in this directory is not an endorsement.